ID Name Structure References (top 5) Molecular Target(s)
1ID:8488
URSOLIC ACID


NSC#:4060
NSC#:114945
NSC#:167406
Aldrich#:301701
Aldrich#:301728
Aldrich#:O5504
Aldrich#:U6753

Freqency:
in 10 ingredients:

  • 20
  • 25
  • 79
  • 176
  • 392
  • 482
  • 669
  • 756
  • 856
  • 899
  • in 83 recipes:

  • 26
  • 28
  • 31
  • 38
  • 45
  • 55
  • 57
  • 58
  • 59
  • 65
  • 68
  • 72
  • 74
  • 91
  • 101
  • 103
  • 108
  • 114
  • 119
  • 121
  • 122
  • 131
  • 135
  • 139
  • 150
  • 152
  • 156
  • 158
  • 167
  • 172
  • 194
  • 195
  • 199
  • 203
  • 226
  • 230
  • 239
  • 245
  • 246
  • 249
  • 250
  • 255
  • 262
  • 276
  • 289
  • 291
  • 293
  • 294
  • 297
  • 303
  • 305
  • 306
  • 307
  • 313
  • 315
  • 322
  • 324
  • 327
  • 343
  • 359
  • 360
  • 371
  • 381
  • 391
  • 398
  • 401
  • 405
  • 409
  • 418
  • 434
  • 436
  • 452
  • 459
  • 466
  • 467
  • 474
  • 477
  • 483
  • 491
  • 499
  • 508
  • 513
  • 523

  • Properties
    C30H48O3    456.7





    1:  Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ.
    Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.
    Cancer Res.    impact factor:   8.614
    2000;  60(9): 2399-404

    2:  Syrovets T, Buchele B, Gedig E, Slupsky JR, Simmet T.
    Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha.
    Mol Pharmacol.    impact factor:   5.465
    2000;  58(1): 71-81

    3:  Miura N, Matsumoto Y, Miyairi S, Nishiyama S, Naganuma A.
    Protective effects of triterpene compounds against the cytotoxicity of cadmium in HepG2 cells.
    Mol Pharmacol.    impact factor:   5.465
    1999;  56(6): 1324-8

    4:  Mizushina Y, Iida A, Ohta K, Sugawara F, Sakaguchi K.
    Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase.
    Biochem J.    impact factor:   4.349
    2000;  350 Pt 3: 757-63

    5:  You HJ, Choi CY, Kim JY, Park SJ, Hahm KS, Jeong HG.
    Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages.
    FEBS Lett.    impact factor:   3.72
    2001;  509(2): 156-60

     
    Time used: 156 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005